ESPR
Esperion Therapeutics Inc
Price:  
2.13 
USD
Volume:  
5,370,484.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR Stock Forecast & Price Target

ESPR Stock Price Forecast

The average stock forecast for Esperion Therapeutics Inc (ESPR) in the next 12 months is 7.56 USD. This price target corresponds to an upside of 255.05%. The range of stock forecasts for ESPR is 2.93 - 16.80 USD. Based on the ratings of 14 analysts, the consensus recommendation for ESPR is BUY.
Target Low Average Median High
Price (USD) 2.93 7.56 8.16 16.80
Upside 37.51% 255.05% 283.10% 688.73%

Recommendation Trends

The latest consensus rating for ESPR is "BUY". This is the average recommendation of 14 analysts: 0 strong sell, 0 sell, 4 hold, 6 buy, 4 strong buy. In the previous period, 14 analysts also majorly recommmended "BUY" for ESPR.

ESPR Financial Stock Forecast

Revenue This Year
265.13M
127.91%
from 116.33M
Revenue Next Year
391.03M
47.48%
from 265.13M
EPS This Year
-0.41
-63.07%
from -1.10
EPS Next Year
0.05
-112.79%
from -0.41